Last $7.30 USD
Change Today 0.00 / 0.00%
Volume 0.0
ARAY On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

accuray inc (ARAY) Snapshot

Open
$6.99
Previous Close
$6.94
Day High
$7.49
Day Low
$6.99
52 Week High
02/3/14 - $10.85
52 Week Low
10/30/14 - $5.99
Market Cap
568.3M
Average Volume 10 Days
819.3K
EPS TTM
$-0.60
Shares Outstanding
77.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACCURAY INC (ARAY)

accuray inc (ARAY) Related Businessweek News

No Related Businessweek News Found

accuray inc (ARAY) Details

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.

1,026 Employees
Last Reported Date: 08/29/14
Founded in 1990

accuray inc (ARAY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $637.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $293.0K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $368.1K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $330.6K
Consultant
Total Annual Compensation: $154.7K
Compensation as of Fiscal Year 2014.

accuray inc (ARAY) Key Developments

Accuray Incorporated Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2014; Reaffirms Financial Guidance for the Year 2015; Provides Cash Flow Guidance for the Second Half of 2015

Accuray Incorporated announced unaudited consolidated earnings results for second quarter and six months ended December 31, 2014. For the quarter, total net revenue was $98,155,000 against $93,634,000 a year ago. Loss from operations was $3,591,000 against $716,000 a year ago. Loss before provision for income taxes was $9,119,000 against $4,491,000 a year ago. Net loss was $9,992,000 or $0.13 per basic and diluted share against $5,441,000 or $0.07 per basic and diluted share a year ago. Adjusted EBITDA was $3,740,000 against $6,781,000 a year ago. Cash usage for the quarter was $1.9 million compared to $19.2 million in the first quarter, so a significant sequential improvement. For the six months, total net revenue was $180,536,000 against $170,275,000 a year ago. Loss from operations was $18,863,000 against $13,002,000 a year ago. Loss before provision for income taxes was $29,852,000 against $19,237,000 a year ago. Net loss was $31,642,000 or $0.41 per basic and diluted share against $20,974,000 or $0.28 per basic and diluted share a year ago. Adjusted EBITDA loss was $4,754,000 against adjusted EBITDA was $2,969,000 a year ago. The company reaffirmed its financial guidance for fiscal year 2015. For the year, the company expects total revenue of $390.0 million to $410.0 million and adjusted EBITDA of $18.0 million to $27.0 million. For the second half, the company is targeting to be cash flow positive, although almost all of that positive cash flow will be generated in the fourth quarter on the high revenues of the year.

Accuray Incorporated Provides Preliminary Revenue Guidance for the Second Quarter Ending December 31, 2014

Accuray Incorporated provided preliminary revenue guidance for the second quarter ending December 31, 2014. For the quarter, the total revenue expected to be in excess of $97 million, an increase of 4% year over year.

Accuray Incorporated to Report Q2, 2015 Results on Jan 27, 2015

Accuray Incorporated announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Jan 27, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARAY:US $7.30 USD +0.36

ARAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr88.85 SEK +0.20
Koninklijke Philips NV €24.73 EUR -0.23
Mitsubishi Heavy Industries Ltd ¥647.50 JPY -4.50
RaySearch Laboratories AB kr53.25 SEK -0.50
Varian Medical Systems Inc $86.52 USD -0.55
View Industry Companies
 

Industry Analysis

ARAY

Industry Average

Valuation ARAY Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCURAY INC, please visit www.accuray.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.